Product Description: Tegobuvir is a specific, covalent inhibitor of the HCV NS5B polymerase.
Applications: COVID-19-anti-virus
Formula: C25H14F7N5
References: [1]Hebner CM, et al. The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function.
PLoS One. 2012;7(6):e39163./[2]Wong KA, et al. Tegobuvir (GS-9190) potency against HCV chimeric replicons derived from consensus NS5B sequences from genotypes 2b, 3a, 4a, 5a, and 6a.
Virology. 2012 Jul 20;429(1):57-62./[3]Bae AS, et al. Allele-specific real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples.
J Clin Microbiol. 2011 Sep;49(9):3168-74.
CAS Number: 1000787-75-6
Molecular Weight: 517.40
Compound Purity: 98.02
Research Area: Infection
Solubility: DMSO : ≥ 50 mg/mL
Target: HCV
English
Deutsch
